Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/30/2008 | CN101167758A Method for preparing antiviral natural polymerization polysaccharide and oligosaccharide |
04/30/2008 | CN101167748A Sterilization haemostatic powder |
04/30/2008 | CN101167737A Application of cimetidine, ribavirin, chlorpheniramine maleate, vitamin B12 and amidopyrine in preparing medicine for treating herpes zoster |
04/30/2008 | CN101167736A Azithromycin microball preparation and preparation method thereof |
04/30/2008 | CN101167732A Method for preparing glycylcycline freezing-dried powder injection |
04/30/2008 | CN101167719A Gallo catechin and gallate microcapsule granule and preparation technique thereof |
04/30/2008 | CN101167715A Skin disinfectant |
04/30/2008 | CN101167712A Chloromycetin eyedrops and preparation method thereof |
04/30/2008 | CN101167708A New use of 6,7-dehydroroyleanone in pharmaceutical |
04/30/2008 | CN101167704A Nosiheptide taste-masked microcapsule and preparation method thereof |
04/30/2008 | CN101167703A Chloromycetin soft capsule and preparation method thereof |
04/30/2008 | CN101167702A Roxoithromycin osmotic pump tablet and preparation method thereof |
04/30/2008 | CN101167692A Chinese medicinal herb health-care foot bath composition |
04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
04/30/2008 | CN100384998C Method for preparing recombinant goose interleukin-2 protein and its application |
04/30/2008 | CN100384988C Chicken astrovirus type 2 |
04/30/2008 | CN100384985C Attenuated eel vibrio strain and its application |
04/30/2008 | CN100384982C Antrodia camphorata mycelium fermented extract and application thereof |
04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
04/30/2008 | CN100384857C Cephalosporin ester compound resisting beta-lactamase and its salt |
04/30/2008 | CN100384845C Process for formulation of antibiotic compounds |
04/30/2008 | CN100384830C Derivative of cyclo membranousol kind and application thereof |
04/30/2008 | CN100384476C Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
04/30/2008 | CN100384472C Antigen-specific lgE antibody production inhibitors |
04/30/2008 | CN100384458C Liver beneficial pharmaceutical composition and method for preparing the same |
04/30/2008 | CN100384440C Chinese medicinal composition for treating animal virus zymosis |
04/30/2008 | CN100384438C Antiviral powder, antiviral extract, and pharmaceutical preparation containing said powder and/or said extract |
04/30/2008 | CN100384431C Traditional Chinese medicine compositions |
04/30/2008 | CN100384427C Injection preparation containing active component adefuwei or its salt and its preparation method |
04/30/2008 | CN100384426C Solid dispersion containing active component adefuwei or its salt and its preparation method |
04/30/2008 | CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
04/30/2008 | CN100384422C Anti-microbial composition comprising a metal ion chelating agent |
04/30/2008 | CN100384414C Medicine containing ketone effective component |
04/29/2008 | US7365191 immunology; antitumor agents; viricides; anticancer agents; antiinflammatory agents; oligosaccharde containing glucose, galactose, mannose |
04/29/2008 | US7365174 Azalide and azalactam derivatives and method for producing the same |
04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
04/29/2008 | US7365169 T-bet antibodies |
04/29/2008 | US7365155 Immunoregulator |
04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
04/29/2008 | US7365071 Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterials |
04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
04/29/2008 | US7365053 Staphylococcal infection; controlling the growth of a microorganism |
04/29/2008 | US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides |
04/29/2008 | US7364749 Preventing scar tissue formation on the trachea, bonchi or alveoli by administering liposomes containing povidone iodine along with an antiinflammatory agent, anesthetic, antioxidant, antibiotic, or corticoid |
04/29/2008 | US7364744 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
04/29/2008 | US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions |
04/29/2008 | US7364739 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections |
04/29/2008 | US7364738 Monoclonal antibodies to the CLFA protein and method of use in treating infections |
04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
04/29/2008 | US7364729 Method of inducing a CTL response |
04/29/2008 | US7364724 Recombinant super-compound interferon |
04/29/2008 | CA2425494C Process for making 3-amino-2-chloro-4-methylpyridine |
04/29/2008 | CA2370098C Human beta-trcp protein |
04/29/2008 | CA2343204C Arylsulfonanilide ureas |
04/29/2008 | CA2338776C Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and .beta.-lactamase inhibitors |
04/29/2008 | CA2305331C Methods for decreasing the frequency of transmission of viral and for preventing and treating bacterial infections using cellulose acetate phthalate or hyroxypropyl methylcellulose phthalate excipients |
04/29/2008 | CA2273074C In ovo vaccination against newcastle disease |
04/29/2008 | CA2268957C Immune response modifier compounds for treatment of th2 mediated and related diseases |
04/29/2008 | CA2177952C Nucleosides and oligonucleotides containing boron clusters |
04/27/2008 | CA2608478A1 Skin disinfectant |
04/24/2008 | WO2008048538A1 Hiv integrase inhibitors |
04/24/2008 | WO2008047909A1 Novel method for production of 1-methylcarbapenem and novel intermediate |
04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
04/24/2008 | WO2008047681A1 Benzimidazole compound having gastric acid secretion inhibitory activity |
04/24/2008 | WO2008047680A1 External preparation for skin |
04/24/2008 | WO2008047658A1 Animal feed additive and animal feed |
04/24/2008 | WO2008047391A1 Nutriceutic composition comprising lactoferrin and proteasic probiotics |
04/24/2008 | WO2008046860A2 Bioavailable combinations for hcv treatment |
04/24/2008 | WO2008046796A2 Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections |
04/24/2008 | WO2008046314A1 The new use of honeysuckle leaf in treating aids |
04/24/2008 | WO2008046251A1 Fusion proteins containing n domain of human calreticulin and human papillomavirus type 16 e6 or e7 and uses thereof |
04/24/2008 | WO2008046202A1 USE OF PYπDOXAL-5'-PHOSPHATE FOR IMPROVING THE IMMUNE RESPONSE AND TREATMENT AND PREVENTION OF POST-OPERATIVE INFECTIONS |
04/24/2008 | WO2008030512A3 Polystyrene sulfonate polymer tablets, their preparation and use |
04/24/2008 | WO2008016300A3 Antibiotic composition |
04/24/2008 | WO2008011116A3 Aza-peptide protease inhibitors |
04/24/2008 | WO2008008537A3 Combi) compositions for the treatment of mucormycosis. comprising iron chelator and antifungal agent |
04/24/2008 | WO2008006979B1 Process for preparing diaminophenothiazinium compounds |
04/24/2008 | WO2008005519A3 Novel pyridazine compound and use thereof |
04/24/2008 | WO2008001166A3 Process for synthesis of glycomimicking cationic amphiphiles |
04/24/2008 | WO2008000881A9 Glycosylated human alpha interferon muteins, method for obtaining them and use |
04/24/2008 | WO2007149730A3 Inhibitors of akt (protein kinase b) |
04/24/2008 | WO2007121125A3 Hcv inhibitors |
04/24/2008 | WO2007112703A3 Pharmaceutical composition containing the nmb0606 protein |
04/24/2008 | WO2007012033A3 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
04/24/2008 | US20080096954 Novel Bicyclic Compounds As Modulators of Androgen Receptor Function And Method |
04/24/2008 | US20080096952 Methods for the treatment of atherosclerosis, using substituted phenethylsulfones |
04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
04/24/2008 | US20080096941 Halogenated benzamide derivatives |
04/24/2008 | US20080096912 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
04/24/2008 | US20080096907 inhibitor of a mycobacteria thymidine monophosphate kinase (TMPK); mycobacteria is M. tuberculosis; leprosy; 5-Methyl-1-(4-bromo-benzyl)-1H-pyrimidine-2,4-dione from reaction of thymine with 4-bromo-benzylbromide; thymine or uracil derivatives |
04/24/2008 | US20080096894 Anti-Bacterial Compounds |
04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
04/24/2008 | US20080096861 Chemical Compounds |
04/24/2008 | US20080096850 Exposing Grampositive bacteria of vagina to a synergistic mixture including hexachlorophene, benzyl paraben, benzyl salicylate, a benzophenone, chlorophene, 2,4-diaminodiphenylamine, dichlorophene, HC Green No. 1, HC Orange No. 1, HC Red No. 1, isopropylbenzyl salicylate, and phenyl salicylate; tampons |